Literature DB >> 22326910

MMP9: a novel function in synaptic plasticity.

Magdalena Dziembowska1, Jakub Wlodarczyk.   

Abstract

Matrix metalloproteinase-9 (MMP-9), an extracellularly acting, Zn(2+)-dependent endopeptidase is a subject to complex regulation at the level of transcription, mRNA dendritic translocation, and local translation as well as protein activation, as it is released extracellularly in a latent, pro-form with the enzymatic site covered by a propeptide that has to be cleaved off to reveal the activity. In neurons, MMP-9 is present at the postsynaptic domains of excitatory synapses. Here, we review the role of MMP-9 in induction of structural dendritic spine modifications and in synaptic plasticity. In particular, we focus on local translation, activity-dependent secretion and activation of MMP-9 leading to its role in long term potentiation and regulation of remodeling of dendritic spines.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326910     DOI: 10.1016/j.biocel.2012.01.023

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  56 in total

Review 1.  Pharmacological therapies for Angelman syndrome.

Authors:  Wen-Hann Tan; Lynne M Bird
Journal:  Wien Med Wochenschr       Date:  2016-01-12

2.  Very long-term memories may be stored in the pattern of holes in the perineuronal net.

Authors:  Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-05       Impact factor: 11.205

3.  Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome.

Authors:  Jonathan W Lovelace; Maham Rais; Arnold R Palacios; Xinghao S Shuai; Steven Bishay; Otilia Popa; Patricia S Pirbhoy; Devin K Binder; David L Nelson; Iryna M Ethell; Khaleel A Razak
Journal:  Cereb Cortex       Date:  2020-03-14       Impact factor: 5.357

4.  Neuroprotective effect of carnosine in the olfactory bulb after vanadium inhalation in a mouse model.

Authors:  Laura Colín-Barenque; Patricia Bizarro-Nevares; Adriana González Villalva; Jose Pedraza-Chaverri; Omar Noel Medina-Campos; Ruben Jimenez-Martínez; Daniela S Rodríguez-Rangel; Stefanie Reséndiz; Teresa I Fortoul
Journal:  Int J Exp Pathol       Date:  2018-09-09       Impact factor: 1.925

Review 5.  Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.

Authors:  Dominic Schomberg; Gurwattan Miranpuri; Tyler Duellman; Andrew Crowell; Raghu Vemuganti; Daniel Resnick
Journal:  Metab Brain Dis       Date:  2015-01-15       Impact factor: 3.584

6.  Resveratrol attenuates the blood-brain barrier dysfunction by regulation of the MMP-9/TIMP-1 balance after cerebral ischemia reperfusion in rats.

Authors:  Haidong Wei; Shiquan Wang; Luming Zhen; Qianzi Yang; Zhixin Wu; Xiaoming Lei; Jianrui Lv; Lize Xiong; Rongliang Xue
Journal:  J Mol Neurosci       Date:  2014-10-21       Impact factor: 3.444

Review 7.  Review of targeted treatments in fragile X syndrome.

Authors:  Andrew Ligsay; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2016-08

8.  Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.

Authors:  Harpreet Sidhu; Lorraine E Dansie; Peter W Hickmott; Douglas W Ethell; Iryna M Ethell
Journal:  J Neurosci       Date:  2014-07-23       Impact factor: 6.167

9.  CD44 Deficiency Is Associated with Increased Susceptibility to Stress-Induced Anxiety-like Behavior in Mice.

Authors:  R Barzilay; F Ventorp; H Segal-Gavish; I Aharony; A Bieber; S Dar; M Vescan; R Globus; A Weizman; D Naor; J Lipton; S Janelidze; L Brundin; D Offen
Journal:  J Mol Neurosci       Date:  2016-09-13       Impact factor: 3.444

10.  Age and Alzheimer's disease gene expression profiles reversed by the glutamate modulator riluzole.

Authors:  A C Pereira; J D Gray; J F Kogan; R L Davidson; T G Rubin; M Okamoto; J H Morrison; B S McEwen
Journal:  Mol Psychiatry       Date:  2016-03-29       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.